Skip to main content
Top
Published in: Inflammation 5/2019

Open Access 01-10-2019 | ORIGINAL ARTICLE

Combustible Cigarette and Smokeless Tobacco Product Preparations Differentially Regulate Intracellular Calcium Mobilization in HL60 Cells

Authors: S. Arimilli, P. Makena, G.L. Prasad

Published in: Inflammation | Issue 5/2019

Login to get access

Abstract

Changes in the level of intracellular calcium ([Ca2+]i) are central to leukocyte signaling and immune response. Although evidence suggests that cigarette smoking affects inflammatory response via an increase in intracellular calcium, it remains unclear if the use of smokeless tobacco (e.g., moist snuff) elicits a similar response. In this study, we evaluated the effects of tobacco product preparations (TPPs), including total particulate matter (TPM) from 3R4F reference cigarettes, smokeless tobacco extract (STE) from 2S3 reference moist snuff, and nicotine alone on Ca2+ mobilization in HL60 cells. Treatment with TPM, but not STE or nicotine alone, significantly increased [Ca2+]i in a concentration-dependent manner in HL60 cells. Moreover, TPM-induced [Ca2+]i increase was not related to extracellular Ca2+ and did not require the activation of the IP3 pathway nor involved the transient receptor potential (TRP) channels. Our findings indicate that, in cells having either intact or depleted endoplasmic reticulum (ER) Ca2+ stores, TPM-mediated [Ca2+]i increase involves cytosolic Ca2+ pools other than thapsigargin-sensitive ER Ca2+ stores. These results, for the first time, demonstrate that TPM triggers [Ca2+]i increases, while significantly higher nicotine equivalent doses of STE or nicotine alone, did not affect [Ca2+]i under the experimental conditions. In summary, our study suggests that in contrast with STE or nicotine preparations, TPM activates Ca2+ signaling pathways in HL60 cells. The differential effect of combustible and non-combustible TPPs on Ca2+ mobilization could be a useful in vitro endpoint for tobacco product evaluation.
Literature
1.
go back to reference Burney, P., B. Kato, C. Janson, D. Mannino, M. Studnicka, W. Tan, E. Bateman, A. Koçabas, W.M. Vollmer, T. Gislason, G. Marks, P.A. Koul, L. Gnatiuc, S. Buist, and Burden of Obstructive Lung Disease (BOLD) Study. 2014. Chronic obstructive pulmonary disease mortality and prevalence: the associations with smoking and poverty: a BOLD analysis—authors’ reply. Thorax 69 (9): 869–870.CrossRefPubMed Burney, P., B. Kato, C. Janson, D. Mannino, M. Studnicka, W. Tan, E. Bateman, A. Koçabas, W.M. Vollmer, T. Gislason, G. Marks, P.A. Koul, L. Gnatiuc, S. Buist, and Burden of Obstructive Lung Disease (BOLD) Study. 2014. Chronic obstructive pulmonary disease mortality and prevalence: the associations with smoking and poverty: a BOLD analysis—authors’ reply. Thorax 69 (9): 869–870.CrossRefPubMed
2.
go back to reference Burns, D.M. 2003. Epidemiology of smoking-induced cardiovascular disease. Progress in Cardiovascular Diseases 46 (1): 11–29.CrossRefPubMed Burns, D.M. 2003. Epidemiology of smoking-induced cardiovascular disease. Progress in Cardiovascular Diseases 46 (1): 11–29.CrossRefPubMed
3.
go back to reference Rosenberg, S.R., and R. Kalhan. 2016. Chronic bronchitis in chronic obstructive pulmonary disease. Magnifying why smoking cessation still matters most. Annals of the American Thoracic Society 13 (7): 999–1000.CrossRefPubMedPubMedCentral Rosenberg, S.R., and R. Kalhan. 2016. Chronic bronchitis in chronic obstructive pulmonary disease. Magnifying why smoking cessation still matters most. Annals of the American Thoracic Society 13 (7): 999–1000.CrossRefPubMedPubMedCentral
4.
go back to reference Keto, J., H. Ventola, J. Jokelainen, K. Linden, S. Keinänen-Kiukaanniemi, M. Timonen, T. Ylisaukko-oja, and J. Auvinen. 2016. Cardiovascular disease risk factors in relation to smoking behaviour and history: a population-based cohort study. Open Heart 3 (2): e000358.CrossRefPubMedPubMedCentral Keto, J., H. Ventola, J. Jokelainen, K. Linden, S. Keinänen-Kiukaanniemi, M. Timonen, T. Ylisaukko-oja, and J. Auvinen. 2016. Cardiovascular disease risk factors in relation to smoking behaviour and history: a population-based cohort study. Open Heart 3 (2): e000358.CrossRefPubMedPubMedCentral
5.
go back to reference National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. 2014. The health consequences of smoking-50 years of progress: a report of the surgeon general. Atlanta (GA): Centers for Disease Control and Prevention (US). National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. 2014. The health consequences of smoking-50 years of progress: a report of the surgeon general. Atlanta (GA): Centers for Disease Control and Prevention (US).
6.
go back to reference Bluhm, A.L., J. Weinstein, and J.A. Sousa. 1971. Free radicals in tobacco smoke. Nature 229 (5285): 500.CrossRefPubMed Bluhm, A.L., J. Weinstein, and J.A. Sousa. 1971. Free radicals in tobacco smoke. Nature 229 (5285): 500.CrossRefPubMed
7.
go back to reference Ding, Y.S., L. Zhang, R.B. Jain, N. Jain, R.Y. Wang, D.L. Ashley, and C.H. Watson. 2008. Levels of tobacco-specific nitrosamines and polycyclic aromatic hydrocarbons in mainstream smoke from different tobacco varieties. Cancer Epidemiology, Biomarkers & Prevention 17 (12): 3366–3371.CrossRef Ding, Y.S., L. Zhang, R.B. Jain, N. Jain, R.Y. Wang, D.L. Ashley, and C.H. Watson. 2008. Levels of tobacco-specific nitrosamines and polycyclic aromatic hydrocarbons in mainstream smoke from different tobacco varieties. Cancer Epidemiology, Biomarkers & Prevention 17 (12): 3366–3371.CrossRef
8.
go back to reference Messner, B., and D. Bernhard. 2014. Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology 34 (3): 509–515.CrossRefPubMed Messner, B., and D. Bernhard. 2014. Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology 34 (3): 509–515.CrossRefPubMed
9.
go back to reference Johannsen, A., C. Susin, and A. Gustafsson. 2014. Smoking and inflammation: evidence for a synergistic role in chronic disease. Periodontol 64 (1): 111–126.CrossRef Johannsen, A., C. Susin, and A. Gustafsson. 2014. Smoking and inflammation: evidence for a synergistic role in chronic disease. Periodontol 64 (1): 111–126.CrossRef
10.
go back to reference Sundar, I.K., H. Yao, and I. Rahman. 2013. Oxidative stress and chromatin remodeling in chronic obstructive pulmonary disease and smoking-related diseases. Antioxidants & Redox Signaling 18 (15): 1956–1971.CrossRef Sundar, I.K., H. Yao, and I. Rahman. 2013. Oxidative stress and chromatin remodeling in chronic obstructive pulmonary disease and smoking-related diseases. Antioxidants & Redox Signaling 18 (15): 1956–1971.CrossRef
11.
go back to reference Lo Tam Loi, A.T., S.J.M. Hoonhorst, L. Franciosi, R. Bischoff, R.F. Hoffmann, I. Heijink, A.J.M. van Oosterhout, H.M. Boezen, W. Timens, D.S. Postma, J.W. Lammers, L. Koenderman, and N.H.T. ten Hacken. 2013. Acute and chronic inflammatory responses induced by smoking in individuals susceptible and non-susceptible to development of COPD: from specific disease phenotyping towards novel therapy. Protocol of a cross-sectional study. BMJ Open 3 (2): e002178.CrossRefPubMedPubMedCentral Lo Tam Loi, A.T., S.J.M. Hoonhorst, L. Franciosi, R. Bischoff, R.F. Hoffmann, I. Heijink, A.J.M. van Oosterhout, H.M. Boezen, W. Timens, D.S. Postma, J.W. Lammers, L. Koenderman, and N.H.T. ten Hacken. 2013. Acute and chronic inflammatory responses induced by smoking in individuals susceptible and non-susceptible to development of COPD: from specific disease phenotyping towards novel therapy. Protocol of a cross-sectional study. BMJ Open 3 (2): e002178.CrossRefPubMedPubMedCentral
12.
go back to reference Lee, J., V. Taneja, and R. Vassallo. 2012. Cigarette smoking and inflammation: cellular and molecular mechanisms. Journal of Dental Research 91 (2): 142–149.CrossRefPubMedPubMedCentral Lee, J., V. Taneja, and R. Vassallo. 2012. Cigarette smoking and inflammation: cellular and molecular mechanisms. Journal of Dental Research 91 (2): 142–149.CrossRefPubMedPubMedCentral
13.
go back to reference Ashley, D.L., et al. 2008. The scientific basis of tobacco product regulation. World Health Organization Technical Report Series (951): 1–277. Ashley, D.L., et al. 2008. The scientific basis of tobacco product regulation. World Health Organization Technical Report Series (951): 1–277.
14.
go back to reference Zeller, M., D. Hatsukami, and Strategic Dialogue on Tobacco Harm Reduction Group. 2009. The strategic dialogue on tobacco harm reduction: a vision and blueprint for action in the US. Tobacco Control 18 (4): 324–332.CrossRefPubMedPubMedCentral Zeller, M., D. Hatsukami, and Strategic Dialogue on Tobacco Harm Reduction Group. 2009. The strategic dialogue on tobacco harm reduction: a vision and blueprint for action in the US. Tobacco Control 18 (4): 324–332.CrossRefPubMedPubMedCentral
15.
16.
go back to reference Hecht, S.S. 2006. Re: Foulds and Ramstrom: cancer causes and control 17: 227-228 (2006) and Henley et al., cancer causes and control 16: 347-358 (2005). How smokeless tobacco can cause lung cancer. Cancer Causes & Control 17 (6): 859–860.CrossRef Hecht, S.S. 2006. Re: Foulds and Ramstrom: cancer causes and control 17: 227-228 (2006) and Henley et al., cancer causes and control 16: 347-358 (2005). How smokeless tobacco can cause lung cancer. Cancer Causes & Control 17 (6): 859–860.CrossRef
17.
go back to reference Royal College of Physicians. 2016. Nicotine without smoke: tobacco harm reduction. London: Royal College of Physicians. Royal College of Physicians. 2016. Nicotine without smoke: tobacco harm reduction. London: Royal College of Physicians.
18.
go back to reference Nutt, D.J., L.D. Phillips, D. Balfour, H.V. Curran, M. Dockrell, J. Foulds, K. Fagerstrom, K. Letlape, A. Milton, R. Polosa, J. Ramsey, and D. Sweanor. 2014. Estimating the harms of nicotine-containing products using the MCDA approach. European Addiction Research 20 (5): 218–225.CrossRefPubMed Nutt, D.J., L.D. Phillips, D. Balfour, H.V. Curran, M. Dockrell, J. Foulds, K. Fagerstrom, K. Letlape, A. Milton, R. Polosa, J. Ramsey, and D. Sweanor. 2014. Estimating the harms of nicotine-containing products using the MCDA approach. European Addiction Research 20 (5): 218–225.CrossRefPubMed
19.
go back to reference Gao, H., G.L. Prasad, and W. Zacharias. 2014. Combusted but not smokeless tobacco products cause DNA damage in oral cavity cells. Environmental Toxicology and Pharmacology 37 (3): 1079–1089.CrossRefPubMed Gao, H., G.L. Prasad, and W. Zacharias. 2014. Combusted but not smokeless tobacco products cause DNA damage in oral cavity cells. Environmental Toxicology and Pharmacology 37 (3): 1079–1089.CrossRefPubMed
20.
go back to reference Malpass, G.E., S. Arimilli, G.L. Prasad, and A.C. Howlett. 2014. Regulation of gene expression by tobacco product preparations in cultured human dermal fibroblasts. Toxicology and Applied Pharmacology 279 (2): 211–219.CrossRefPubMedPubMedCentral Malpass, G.E., S. Arimilli, G.L. Prasad, and A.C. Howlett. 2014. Regulation of gene expression by tobacco product preparations in cultured human dermal fibroblasts. Toxicology and Applied Pharmacology 279 (2): 211–219.CrossRefPubMedPubMedCentral
21.
go back to reference Arimilli, S., B.E. Damratoski, and G.L. Prasad. 2013. Combustible and non-combustible tobacco product preparations differentially regulate human peripheral blood mononuclear cell functions. Toxicology In Vitro 27 (6): 1992–2004.CrossRefPubMed Arimilli, S., B.E. Damratoski, and G.L. Prasad. 2013. Combustible and non-combustible tobacco product preparations differentially regulate human peripheral blood mononuclear cell functions. Toxicology In Vitro 27 (6): 1992–2004.CrossRefPubMed
22.
go back to reference Holt, P.G., and D. Keast. 1977. Environmentally induced changes in immunological function: acute and chronic effects of inhalation of tobacco smoke and other atmospheric contaminants in man and experimental animals. Bacteriological Reviews 41 (1): 205–216.PubMedPubMedCentral Holt, P.G., and D. Keast. 1977. Environmentally induced changes in immunological function: acute and chronic effects of inhalation of tobacco smoke and other atmospheric contaminants in man and experimental animals. Bacteriological Reviews 41 (1): 205–216.PubMedPubMedCentral
23.
go back to reference Qiu, S.L., H. Zhang, Q.Y. Tang, J. Bai, Z.Y. He, J.Q. Zhang, M.H. Li, J.M. Deng, G.N. Liu, and X.N. Zhong. 2017. Neutrophil extracellular traps induced by cigarette smoke activate plasmacytoid dendritic cells. Thorax 72 (12): 1084–1093.CrossRefPubMed Qiu, S.L., H. Zhang, Q.Y. Tang, J. Bai, Z.Y. He, J.Q. Zhang, M.H. Li, J.M. Deng, G.N. Liu, and X.N. Zhong. 2017. Neutrophil extracellular traps induced by cigarette smoke activate plasmacytoid dendritic cells. Thorax 72 (12): 1084–1093.CrossRefPubMed
24.
go back to reference Kislina, A., L. Balode, N. Jurka, Z. Sinkevica, S. Isajevs, D. Isajeva, V. Gordjusina, M. Bukovskis, I. Taivans, and G. Strazda. 2015. Increased innate and adaptive immune responses in induced sputum of young smokers. Medicina (Kaunas, Lithuania) 51 (3): 159–166.CrossRef Kislina, A., L. Balode, N. Jurka, Z. Sinkevica, S. Isajevs, D. Isajeva, V. Gordjusina, M. Bukovskis, I. Taivans, and G. Strazda. 2015. Increased innate and adaptive immune responses in induced sputum of young smokers. Medicina (Kaunas, Lithuania) 51 (3): 159–166.CrossRef
25.
go back to reference Green, R.M., F. Gally, J.G. Keeney, S. Alper, B. Gao, M. Han, R.J. Martin, A.R. Weinberger, S.R. Case, M.N. Minor, and H.W. Chu. 2009. Impact of cigarette smoke exposure on innate immunity: a Caenorhabditis elegans model. PLoS One 4 (8): e6860.CrossRefPubMedPubMedCentral Green, R.M., F. Gally, J.G. Keeney, S. Alper, B. Gao, M. Han, R.J. Martin, A.R. Weinberger, S.R. Case, M.N. Minor, and H.W. Chu. 2009. Impact of cigarette smoke exposure on innate immunity: a Caenorhabditis elegans model. PLoS One 4 (8): e6860.CrossRefPubMedPubMedCentral
26.
go back to reference Willis, D., et al. 2012. Toxicology of smokeless tobacco: implications for immune, reproductive, and cardiovascular systems. Journal of Toxicology and Environmental Health Part B, Critical Reviews 15 (5): 317–331.CrossRefPubMed Willis, D., et al. 2012. Toxicology of smokeless tobacco: implications for immune, reproductive, and cardiovascular systems. Journal of Toxicology and Environmental Health Part B, Critical Reviews 15 (5): 317–331.CrossRefPubMed
27.
go back to reference Arimilli, S., B.E. Damratoski, and L.P. G. 2015. Methods to evaluate cytotoxicity and immunosuppression of combustible tobacco product preparations. Journal of Visualized Experiments (95): 52351. Arimilli, S., B.E. Damratoski, and L.P. G. 2015. Methods to evaluate cytotoxicity and immunosuppression of combustible tobacco product preparations. Journal of Visualized Experiments (95): 52351.
28.
go back to reference Putney, J.W., Jr., Broad, L.M., Braun, F.J., Lievremont, J.P., Bird, G.S. 2001. Mechanisms of capacitative calcium entry. Journal of Cell Science 114 (12): 2223–2229. Putney, J.W., Jr., Broad, L.M., Braun, F.J., Lievremont, J.P., Bird, G.S. 2001. Mechanisms of capacitative calcium entry. Journal of Cell Science 114 (12): 2223–2229.
29.
go back to reference Sachs, F. 2010. Stretch-activated ion channels: what are they? Physiology (Bethesda) 25 (1): 50–56. Sachs, F. 2010. Stretch-activated ion channels: what are they? Physiology (Bethesda) 25 (1): 50–56.
30.
go back to reference Cho, M.R., et al. 1999. Transmembrane calcium influx induced by ac electric fields. The FASEB Journal 13 (6): 677–683.CrossRefPubMed Cho, M.R., et al. 1999. Transmembrane calcium influx induced by ac electric fields. The FASEB Journal 13 (6): 677–683.CrossRefPubMed
32.
go back to reference Putney, J.W., Jr. 1997. Type 3 inositol 1,4,5-trisphosphate receptor and capacitative calcium entry. Cell Calcium 21 (3): 257–261.CrossRefPubMed Putney, J.W., Jr. 1997. Type 3 inositol 1,4,5-trisphosphate receptor and capacitative calcium entry. Cell Calcium 21 (3): 257–261.CrossRefPubMed
33.
34.
go back to reference Philipp, S., B. Strauss, D. Hirnet, U. Wissenbach, L. Méry, V. Flockerzi, and M. Hoth. 2003. TRPC3 mediates T-cell receptor-dependent calcium entry in human T-lymphocytes. The Journal of Biological Chemistry 278 (29): 26629–26638.CrossRefPubMed Philipp, S., B. Strauss, D. Hirnet, U. Wissenbach, L. Méry, V. Flockerzi, and M. Hoth. 2003. TRPC3 mediates T-cell receptor-dependent calcium entry in human T-lymphocytes. The Journal of Biological Chemistry 278 (29): 26629–26638.CrossRefPubMed
36.
go back to reference Venkatachalam, K., H.T. Ma, D.L. Ford, and D.L. Gill. 2001. Expression of functional receptor-coupled TRPC3 channels in DT40 triple receptor InsP3 knockout cells. The Journal of Biological Chemistry 276 (36): 33980–33985.CrossRefPubMed Venkatachalam, K., H.T. Ma, D.L. Ford, and D.L. Gill. 2001. Expression of functional receptor-coupled TRPC3 channels in DT40 triple receptor InsP3 knockout cells. The Journal of Biological Chemistry 276 (36): 33980–33985.CrossRefPubMed
37.
go back to reference Bertin, S., et al. 2014. The ion channel TRPV1 regulates the activation and proinflammatory properties of CD4(+) T cells. Nature Immunology 15 (11): 1055–1063.CrossRefPubMedPubMedCentral Bertin, S., et al. 2014. The ion channel TRPV1 regulates the activation and proinflammatory properties of CD4(+) T cells. Nature Immunology 15 (11): 1055–1063.CrossRefPubMedPubMedCentral
38.
go back to reference Gouy, H., D. Cefai, S.B. Christensen, P. Debré, and G. Bismuth. 1990. Ca2+ influx in human T lymphocytes is induced independently of inositol phosphate production by mobilization of intracellular Ca2+ stores. A study with the Ca2+ endoplasmic reticulum-ATPase inhibitor thapsigargin. European Journal of Immunology 20 (10): 2269–2275.CrossRefPubMed Gouy, H., D. Cefai, S.B. Christensen, P. Debré, and G. Bismuth. 1990. Ca2+ influx in human T lymphocytes is induced independently of inositol phosphate production by mobilization of intracellular Ca2+ stores. A study with the Ca2+ endoplasmic reticulum-ATPase inhibitor thapsigargin. European Journal of Immunology 20 (10): 2269–2275.CrossRefPubMed
39.
go back to reference Telford, W.G., and R.A. Miller. 1996. Detection of plasma membrane Ca(2+)-ATPase activity in mouse T lymphocytes by flow cytometry using fluo-3-loaded vesicles. Cytometry 24 (3): 243–250.CrossRefPubMed Telford, W.G., and R.A. Miller. 1996. Detection of plasma membrane Ca(2+)-ATPase activity in mouse T lymphocytes by flow cytometry using fluo-3-loaded vesicles. Cytometry 24 (3): 243–250.CrossRefPubMed
40.
go back to reference Bautista, D.M., M. Hoth, and R.S. Lewis. 2002. Enhancement of calcium signalling dynamics and stability by delayed modulation of the plasma-membrane calcium-ATPase in human T cells. The Journal of Physiology 541(Pt 3: 877–894.CrossRefPubMedPubMedCentral Bautista, D.M., M. Hoth, and R.S. Lewis. 2002. Enhancement of calcium signalling dynamics and stability by delayed modulation of the plasma-membrane calcium-ATPase in human T cells. The Journal of Physiology 541(Pt 3: 877–894.CrossRefPubMedPubMedCentral
41.
go back to reference Hallett, M.B., and D. Lloyds. 1997. The molecular and ionic signaling of neutrophils. Molecular Biology Intelligence Unit, 180. Berlin/Heidelberg: Springer-Verlag Berlin and Heidelberg GmbH & Co. Hallett, M.B., and D. Lloyds. 1997. The molecular and ionic signaling of neutrophils. Molecular Biology Intelligence Unit, 180. Berlin/Heidelberg: Springer-Verlag Berlin and Heidelberg GmbH & Co.
42.
go back to reference Parekh, A.B., and J.W. Putney Jr. 2005. Store-operated calcium channels. Physiological Reviews 85 (2): 757–810.CrossRefPubMed Parekh, A.B., and J.W. Putney Jr. 2005. Store-operated calcium channels. Physiological Reviews 85 (2): 757–810.CrossRefPubMed
43.
go back to reference Arimilli, S., E. Schmidt, B.E. Damratoski, and G.L. Prasad. 2017. Role of oxidative stress in the suppression of immune responses in peripheral blood mononuclear cells exposed to combustible tobacco product preparation. Inflammation 40 (5): 1622–1630.CrossRefPubMedPubMedCentral Arimilli, S., E. Schmidt, B.E. Damratoski, and G.L. Prasad. 2017. Role of oxidative stress in the suppression of immune responses in peripheral blood mononuclear cells exposed to combustible tobacco product preparation. Inflammation 40 (5): 1622–1630.CrossRefPubMedPubMedCentral
44.
go back to reference Misra, M., R. Leverette, B. Cooper, M. Bennett, and S. Brown. 2014. Comparative in vitro toxicity profile of electronic and tobacco cigarettes, smokeless tobacco and nicotine replacement therapy products: e-liquids, extracts and collected aerosols. International Journal of Environmental Research and Public Health 11 (11): 11325–11347.CrossRefPubMedPubMedCentral Misra, M., R. Leverette, B. Cooper, M. Bennett, and S. Brown. 2014. Comparative in vitro toxicity profile of electronic and tobacco cigarettes, smokeless tobacco and nicotine replacement therapy products: e-liquids, extracts and collected aerosols. International Journal of Environmental Research and Public Health 11 (11): 11325–11347.CrossRefPubMedPubMedCentral
45.
go back to reference Arimilli, S., B.E. Damratoski, B. Bombick, M.F. Borgerding, and G.L. Prasad. 2012. Evaluation of cytotoxicity of different tobacco product preparations. Regulatory Toxicology and Pharmacology 64 (3): 350–360.CrossRefPubMed Arimilli, S., B.E. Damratoski, B. Bombick, M.F. Borgerding, and G.L. Prasad. 2012. Evaluation of cytotoxicity of different tobacco product preparations. Regulatory Toxicology and Pharmacology 64 (3): 350–360.CrossRefPubMed
46.
go back to reference Wylam, M.E., V. Sathish, S.K. VanOosten, M. Freeman, D. Burkholder, M.A. Thompson, C.M. Pabelick, and Y.S. Prakash. 2015. Mechanisms of cigarette smoke effects on human airway smooth muscle. PLoS One 10 (6): e0128778.CrossRefPubMedPubMedCentral Wylam, M.E., V. Sathish, S.K. VanOosten, M. Freeman, D. Burkholder, M.A. Thompson, C.M. Pabelick, and Y.S. Prakash. 2015. Mechanisms of cigarette smoke effects on human airway smooth muscle. PLoS One 10 (6): e0128778.CrossRefPubMedPubMedCentral
47.
go back to reference Rasmussen, J.E., J.T. Sheridan, W. Polk, C.M. Davies, and R. Tarran. 2014. Cigarette smoke-induced Ca2+ release leads to cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction. The Journal of Biological Chemistry 289 (11): 7671–7681.CrossRefPubMedPubMedCentral Rasmussen, J.E., J.T. Sheridan, W. Polk, C.M. Davies, and R. Tarran. 2014. Cigarette smoke-induced Ca2+ release leads to cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction. The Journal of Biological Chemistry 289 (11): 7671–7681.CrossRefPubMedPubMedCentral
48.
go back to reference Sassano, M.F., A. Ghosh, and R. Tarran. 2017. Tobacco smoke constituents trigger cytoplasmic calcium release. Applied In Vitro Toxicology 3 (2): 193–198.CrossRefPubMedPubMedCentral Sassano, M.F., A. Ghosh, and R. Tarran. 2017. Tobacco smoke constituents trigger cytoplasmic calcium release. Applied In Vitro Toxicology 3 (2): 193–198.CrossRefPubMedPubMedCentral
49.
go back to reference Mai, Y., T. Higashi, K. Terada, C. Hatate, P. Nepal, M. Horiguchi, T. Harada, S. Miwa, and T. Horinouchi. 2012. Nicotine- and tar-free cigarette smoke extract induces cell injury via intracellular Ca2+-dependent subtype-specific protein kinase C activation. Journal of Pharmacological Sciences 120 (4): 310–314.CrossRefPubMed Mai, Y., T. Higashi, K. Terada, C. Hatate, P. Nepal, M. Horiguchi, T. Harada, S. Miwa, and T. Horinouchi. 2012. Nicotine- and tar-free cigarette smoke extract induces cell injury via intracellular Ca2+-dependent subtype-specific protein kinase C activation. Journal of Pharmacological Sciences 120 (4): 310–314.CrossRefPubMed
50.
go back to reference Venkateswaran, K., A. Verma, A.N. Bhatt, A. Shrivastava, K. Manda, H.G. Raj, A. Prasad, C. Len, V.S. Parmar, and B.S. Dwarakanath. 2018. Emerging roles of calreticulin in cancer: implications for therapy. Current Protein & Peptide Science 19 (4): 344–357.CrossRef Venkateswaran, K., A. Verma, A.N. Bhatt, A. Shrivastava, K. Manda, H.G. Raj, A. Prasad, C. Len, V.S. Parmar, and B.S. Dwarakanath. 2018. Emerging roles of calreticulin in cancer: implications for therapy. Current Protein & Peptide Science 19 (4): 344–357.CrossRef
51.
go back to reference Chemaly, E.R., L. Troncone, and D. Lebeche. 2018. SERCA control of cell death and survival. Cell Calcium 69: 46–61.CrossRefPubMed Chemaly, E.R., L. Troncone, and D. Lebeche. 2018. SERCA control of cell death and survival. Cell Calcium 69: 46–61.CrossRefPubMed
52.
go back to reference Danese, A., S. Patergnani, M. Bonora, M.R. Wieckowski, M. Previati, C. Giorgi, and P. Pinton. 2017. Calcium regulates cell death in cancer: roles of the mitochondria and mitochondria-associated membranes (MAMs). Biochimica et Biophysica Acta - Bioenergetics 1858 (8): 615–627.CrossRefPubMed Danese, A., S. Patergnani, M. Bonora, M.R. Wieckowski, M. Previati, C. Giorgi, and P. Pinton. 2017. Calcium regulates cell death in cancer: roles of the mitochondria and mitochondria-associated membranes (MAMs). Biochimica et Biophysica Acta - Bioenergetics 1858 (8): 615–627.CrossRefPubMed
53.
go back to reference Voelkers, M., et al. 2010. Orai1 and Stim1 regulate normal and hypertrophic growth in cardiomyocytes. Journal of Molecular and Cellular Cardiology 48 (6): 1329–1334.CrossRefPubMedPubMedCentral Voelkers, M., et al. 2010. Orai1 and Stim1 regulate normal and hypertrophic growth in cardiomyocytes. Journal of Molecular and Cellular Cardiology 48 (6): 1329–1334.CrossRefPubMedPubMedCentral
Metadata
Title
Combustible Cigarette and Smokeless Tobacco Product Preparations Differentially Regulate Intracellular Calcium Mobilization in HL60 Cells
Authors
S. Arimilli
P. Makena
G.L. Prasad
Publication date
01-10-2019
Publisher
Springer US
Published in
Inflammation / Issue 5/2019
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-019-01025-x

Other articles of this Issue 5/2019

Inflammation 5/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.